JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
Zoë S. Walters(Institute of Cancer Research), Janet Shipley(Institute of Cancer Research)
Cited by 105
Related Papers
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance
|The Journal of Pathology|2017|29
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
|BMC Cancer|2018|28
FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
|Molecular Oncology|2021|18